<--- Back to Details
First PageDocument Content
Medicinal chemistry / Pharmaceutical sciences / Cytochrome P450 / Science / Computational chemistry / Quantitative structure–activity relationship / CYP2C9 / Applicability Domain / CYP3A4 / Chemistry / Pharmacology / Cheminformatics
Date: 2011-02-09 07:59:13
Medicinal chemistry
Pharmaceutical sciences
Cytochrome P450
Science
Computational chemistry
Quantitative structure–activity relationship
CYP2C9
Applicability Domain
CYP3A4
Chemistry
Pharmacology
Cheminformatics

Add to Reading List

Source URL: www.acdlabs.com

Download Document from Source Website

File Size: 350,29 KB

Share Document on Facebook

Similar Documents

ProCube® W_CYP2C9(b5)  recombinant human CYP2C9 (+b5) microsomes

ProCube® W_CYP2C9(b5) recombinant human CYP2C9 (+b5) microsomes

DocID: 1ui1a - View Document

Impact of Concomitant Antiretrovirals, and CYP2C9 and CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine 1  2

Impact of Concomitant Antiretrovirals, and CYP2C9 and CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine 1 2

DocID: 1omXF - View Document

Chapter 4. Pharmacogenetics and Pharmacogenomics  Kim Brøsen, M.D., Ph.D. Institute of Public Health Clinical Pharmacology University of Southern Denmark

Chapter 4. Pharmacogenetics and Pharmacogenomics Kim Brøsen, M.D., Ph.D. Institute of Public Health Clinical Pharmacology University of Southern Denmark

DocID: 1aYno - View Document

CYP2C9 CYP2C9 Genotype2 nmd4 nmd nmd

CYP2C9 CYP2C9 Genotype2 nmd4 nmd nmd

DocID: 18mo5 - View Document

CYP2C9 and VKORC11 CYP2C9 2  VKORC1

CYP2C9 and VKORC11 CYP2C9 2 VKORC1

DocID: 180Qn - View Document